GWM
BCAT icon

Geneos Wealth Management’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Geneos Wealth Management’s Portfolio BCAT Stock Details BCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,045
Closed -$31K – 2553
2025
Q2 		$31K Buy
2,045
+1,582
+342% +$23.1K ﹤0.01% 1816
2025
Q1 		$98.6K Buy
+463
New +$7.07K ﹤0.01% 1585

Other funds holding BCAT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geneos Wealth Management's BCAT Position: Q3 2025 in Review

Geneos Wealth Management sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2025, closing a stake of 2,045 shares — an estimated $31K sold.

Geneos Wealth Management first reported a position in BCAT in Q1 2025 and held it in 2 quarters. The position peaked at $98.6K in Q1 2025. 94 funds tracked by Wall St. Rank hold BCAT as of Q3 2025.

  • Geneos Wealth Management reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 2,045 BlackRock Capital Allocation Term Trust shares in Q3 2025, an estimated $31K.
  • Geneos Wealth Management first reported a position in BlackRock Capital Allocation Term Trust in Q1 2025 and held it in 2 quarters.
  • Geneos Wealth Management's BlackRock Capital Allocation Term Trust position peaked at $98.6K in Q1 2025.
  • 94 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.